PAVmed Future Growth
Future criteria checks 2/6
PAVmed is forecast to grow earnings and revenue by 25.5% and 74.9% per annum respectively while EPS is expected to grow by 29.9% per annum.
Key information
25.5%
Earnings growth rate
29.9%
EPS growth rate
Medical Equipment earnings growth | 18.1% |
Revenue growth rate | 74.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 8 | -89 | -73 | N/A | 1 |
12/31/2023 | 10 | -91 | -86 | -62 | 4 |
12/31/2022 | 1 | -92 | -90 | -68 | 3 |
9/30/2022 | 1 | -86 | -73 | -71 | N/A |
6/30/2022 | 1 | -72 | -62 | -60 | N/A |
3/31/2022 | 1 | -58 | -46 | -44 | N/A |
12/31/2021 | 1 | -51 | -42 | -41 | N/A |
9/30/2021 | 0 | -42 | -31 | -31 | N/A |
6/30/2021 | N/A | -35 | -29 | -28 | N/A |
3/31/2021 | N/A | -30 | -27 | -27 | N/A |
12/31/2020 | N/A | -35 | -22 | -22 | N/A |
9/30/2020 | N/A | -32 | -19 | -19 | N/A |
6/30/2020 | N/A | -30 | -16 | -16 | N/A |
3/31/2020 | N/A | -28 | -13 | -13 | N/A |
12/31/2019 | N/A | -17 | -13 | -13 | N/A |
9/30/2019 | N/A | -17 | -12 | -12 | N/A |
6/30/2019 | N/A | -17 | -11 | -11 | N/A |
3/31/2019 | N/A | -19 | -10 | -10 | N/A |
12/31/2018 | N/A | -19 | -9 | -9 | N/A |
9/30/2018 | N/A | -12 | -7 | -7 | N/A |
6/30/2018 | N/A | -14 | -8 | -8 | N/A |
3/31/2018 | N/A | -10 | -7 | -7 | N/A |
12/31/2017 | N/A | -10 | -7 | -7 | N/A |
9/30/2017 | N/A | -12 | -6 | -6 | N/A |
6/30/2017 | N/A | -9 | -5 | -5 | N/A |
3/31/2017 | N/A | -9 | -6 | -6 | N/A |
12/31/2016 | N/A | -6 | -4 | -4 | N/A |
9/30/2016 | N/A | -5 | -4 | -4 | N/A |
6/30/2016 | N/A | -3 | N/A | -3 | N/A |
3/31/2016 | N/A | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1P5 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 1P5 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 1P5 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 1P5's revenue (74.9% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 1P5's revenue (74.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1P5's Return on Equity is forecast to be high in 3 years time